Intervention Review

Hormonal therapy in advanced or recurrent endometrial cancer

  1. Fani Kokka1,*,
  2. Elly Brockbank2,
  3. David Oram2,
  4. Chris Gallagher3,
  5. Andrew Bryant4

Editorial Group: Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group

Published Online: 8 DEC 2010

Assessed as up-to-date: 9 NOV 2010

DOI: 10.1002/14651858.CD007926.pub2

How to Cite

Kokka F, Brockbank E, Oram D, Gallagher C, Bryant A. Hormonal therapy in advanced or recurrent endometrial cancer. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD007926. DOI: 10.1002/14651858.CD007926.pub2.

Author Information

  1. 1

    Queen Elizabeth The Queen Mother Hospital, Women's Health, Birchington Ward, Kent, UK

  2. 2

    St. Bartholomew's Hospital, Department of Gynaecological Oncology, London, UK

  3. 3

    St Bartholomew's Hospital, Medical Oncology, London, UK

  4. 4

    Newcastle University, Institute of Health & Society, Newcastle upon Tyne, UK

*Fani Kokka, Women's Health, Birchington Ward, Queen Elizabeth The Queen Mother Hospital, St Peters Road, Kent, CT9 4AN, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 DEC 2010


Cited in:


This article has been cited by:

  1. 1
    David Archampong, Helen Sweetland, Endocrine therapy in cancer care, Surgery (Oxford), 2015, 33, 3, 122


  2. 2
    Sota Tanaka, Yasuhiro Miki, Chiaki Hashimoto, Kiyoshi Takagi, Zhulanqiqige Doe, Bin Li, Nobuo Yaegashi, Takashi Suzuki, Kiyoshi Ito, The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma, Molecular and Cellular Endocrinology, 2015, 401, 56


  3. 3
    Jae-Seung Lee, Ji-Hye Ahn, Yoon-Jin Cho, Ha-Yeong Kim, Yeong-In Yang, Kyung-Tae Lee, Dae-Sik Jang, Jung-Hye Choi, α-Terthienylmethanol, isolated from Eclipta prostrata, induces apoptosis by generating reactive oxygen species via NADPH oxidase in human endometrial cancer cells, Journal of Ethnopharmacology, 2015, 169, 426


  4. 4
    Facharzt Hämatologie Onkologie, 2015,


  5. 5
    Yu-Ping Liu, Jiahu Wang, Victoria A. Avanzato, Jamie N. Bakkum-Gamez, Stephen J. Russell, John C. Bell, Kah-Whye Peng, Oncolytic vaccinia virotherapy for endometrial cancer, Gynecologic Oncology, 2014, 132, 3, 722


  6. 6
    Günter Emons, Andreas Günthert, Falk C. Thiel, Oumar Camara, Hans-Georg Strauss, Georg-Peter Breitbach, Heinz Kölbl, Toralf Reimer, Dominique Finas, Klaus Rensing, Phase II study of fulvestrant 250mg/month in patients with recurrent or metastatic endometrial cancer: A study of the Arbeitsgemeinschaft Gynäkologische Onkologie, Gynecologic Oncology, 2013, 129, 3, 495


  7. 7
    Daniel Hanratty, Helen Sweetland, Role of endocrine therapy in cancer treatment, Surgery (Oxford), 2012, 30, 4, 194


  8. 8
    Khadra Galaal, Mansour Al Moundhri, Andrew Bryant, Alberto D Lopes, Theresa A Lawrie, Adjuvant chemotherapy for advanced endometrial cancer, The Cochrane Library,
  9. 9
    Claire L Vale, Jayne Tierney, Sarah J Bull, Paul R Symonds, Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma, The Cochrane Library,
  10. 10
    Khadra Galaal, Mansour Al Moundhri, Andrew Bryant, Alberto D Lopes, Surgery and chemotherapy with or without radiotherapy for disseminated advanced endometrial cancer, The Cochrane Library,